These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 15363465)

  • 1. The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer.
    Tambaro R; Scambia G; Di Maio M; Pisano C; Barletta E; Iaffaioli VR; Pignata S
    Crit Rev Oncol Hematol; 2004 Oct; 52(1):33-44. PubMed ID: 15363465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of systemic chemotherapy in metastatic cervical cancer.
    Hogg R; Friedlander M
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):234-40. PubMed ID: 12722882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined-modality therapy of locally advanced cervical cancer.
    Rose PG
    J Clin Oncol; 2003 May; 21(10 Suppl):211s-217s. PubMed ID: 12743137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for recurrent cervical cancer.
    Pectasides D; Kamposioras K; Papaxoinis G; Pectasides E
    Cancer Treat Rev; 2008 Nov; 34(7):603-13. PubMed ID: 18657909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for recurrent and metastatic cervical cancer.
    Tao X; Hu W; Ramirez PT; Kavanagh JJ
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S67-71. PubMed ID: 18533239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of concurrent chemoradiation in comparison with radiation alone in locally advanced cervical cancer.
    Manusirivithaya S; Sripramote M; Tangjitgamol S; Sanjareonsuttikul N; Pisarnturakit P
    J Med Assoc Thai; 2005 Aug; 88(8):1035-44. PubMed ID: 16404829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group.
    Tewari KS; Monk BJ
    Semin Oncol; 2009 Apr; 36(2):170-80. PubMed ID: 19332251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy and concurrent chemoradiation in the treatment of advanced cervical cancer.
    Gadducci A; Cosio S; Cionini L; Genazzani AR
    Anticancer Res; 2001; 21(5):3525-33. PubMed ID: 11848519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy in the management of cervical carcinoma.
    duPont NC; Monk BJ
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):279-86. PubMed ID: 16728939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer.
    Borowsky ME; Elliott KS; Pezzullo JC; Santoso P; Choi W; Choi K; Abulafia O
    Bull Cancer; 2005 Feb; 92(2):E19-24. PubMed ID: 15749639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel chemotherapy approaches in chemoradiation protocols.
    González-Cortijo L; Carballo N; González-Martín A; Corraliza V; Chiva de Agustín L; Lapuente Sastre F; García García JF; Rojo Sebastián A; Hornedo J; Colomer R
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S45-8. PubMed ID: 18678399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent cisplatin-based chemoradiation and adjuvant hysterectomy for bulky stage IB-IIA cervical cancer.
    Cheewakriangkrai C; Srisomboon J; Chitapanarux I; Suprasert P; Phongnarisorn C; Siriaree S; Charoenkwan K
    J Med Assoc Thai; 2005 Oct; 88(10):1331-7. PubMed ID: 16519375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer.
    Loizzi V; Cormio G; Vicino M; Selvaggi L
    Gynecol Obstet Invest; 2008; 65(2):96-103. PubMed ID: 17878736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of cervical cancer.
    Legge F; Fuoco G; Lorusso D; Lucidi A; Borriello M; Pisconti S; Scambia G; Ferrandina G
    Expert Opin Pharmacother; 2010 Aug; 11(12):2059-75. PubMed ID: 20642372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenesis agents in metastatic or recurrent cervical cancer.
    Monk BJ; Willmott LJ; Sumner DA
    Gynecol Oncol; 2010 Feb; 116(2):181-6. PubMed ID: 19861227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer.
    Eifel PJ
    Nat Clin Pract Oncol; 2006 May; 3(5):248-55. PubMed ID: 16683003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.